These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1491182)

  • 1. Tissue polypeptide antigen (TPA) in chronic active hepatitis and mild liver diseases.
    Collazos J; Genollà J; Ruibal A
    Int J Biol Markers; 1992; 7(4):249-52. PubMed ID: 1491182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical and biochemical study on tissue polypeptide antigen (TPA) in non-malignant hepatic disorders.
    Collazos J; Genollá J; Ruibal A
    Scand J Clin Lab Invest; 1993 Oct; 53(6):633-7. PubMed ID: 8266011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of tissue polypeptide specific antigen as a marker in liver diseases.
    Cetin T; Oğuz A; Algan P; Yildirim IS
    Turk J Gastroenterol; 2003 Sep; 14(3):177-80. PubMed ID: 14655061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue polypeptide specific antigen as a marker used to determine the liver diseases.
    Paul D; Biswas R; Habib SH
    Kathmandu Univ Med J (KUMJ); 2011; 9(33):24-7. PubMed ID: 22610804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue polypeptide antigen (TPA) modifications in hepatic cirrhosis, aggressive chronic hepatitis, persistent chronic hepatitis, and in minimal pathology.
    Sabbatani S; Monti M; Fini A
    Int J Biol Markers; 1988; 3(2):127-8. PubMed ID: 3243978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of tissue polypeptide antigen (TPA) in hepatic and systemic circulation in patients with chronic liver diseases.
    Puoti C; Bellis L; Guarisco R; Costanza OM; Felici R; Spilabotti L; Paglia F; Galossi A; Dell' Unto O
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1847-51. PubMed ID: 19686414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical and laboratory evaluation of the behavior of tissue polypeptide antigen in liver cirrhosis.
    Collazos J; Genollá J; Ruibal A
    Digestion; 1992; 53(3-4):157-61. PubMed ID: 1291404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders.
    Gallo V; Cerutti E; Riberi A; Re M; Petrino R; Pecchio F
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):89-93. PubMed ID: 2480432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker].
    Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
    Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Matsushima M; Kuwabara T; Miyamae K; Hachiya A; Kawahara M; Fukasawa K; Yagishita T; Tajima M; Sawamura Y; Shirai M
    Hinyokika Kiyo; 1984 Jul; 30(7):869-75. PubMed ID: 6507205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycocholic acid in chronic active hepatitis and mild liver diseases.
    Collazos J
    Clin Investig; 1993 Dec; 72(1):36-9. PubMed ID: 8136614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
    Pagani A; Zigliani P; Pranzo A; Galante T
    Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of BEKI TPS radioassay kit as a one-step immunoradiometric assay utilizes monoclonal and polyclonal antibodies specific for serum tissue polypeptide antigen].
    Hamase A; Kawanaka M; Kitani H; Fukuchi M
    Kaku Igaku; 1994 Aug; 31(8):995-1003. PubMed ID: 7933689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring lung cancer with tissue polypeptide antigen: an ancillary, profitable serum test to evaluate treatment response and posttreatment disease status.
    Buccheri G; Ferrigno D
    Lung Cancer; 1995 Oct; 13(2):155-68. PubMed ID: 8581395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit].
    Sakahara H; Endo K; Torizuka K; Itoh K; Ohuchi N; Inaba N; Miyaji Y; Takayama M; Ishii K; Takagi H; Konishi J; Fukuoka M; Fukuchi M; Ohkawa J; Kagawa S; Kondo S; Shirouzu K; Iguchi H
    Gan To Kagaku Ryoho; 1996 May; 23(6):733-43. PubMed ID: 8645025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer.
    Lee YC; Yang PC; Kuo SH; Luh KT
    J Formos Med Assoc; 1991 Jul; 90(7):631-6. PubMed ID: 1681012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of cytokeratin-18 (tissue polypeptide-specific antigen) in liver diseases.
    Gonzalez-Quintela A; Mallo N; Mella C; Campos J; Perez LF; Lopez-Rodriguez R; Tome S; Otero E
    Liver Int; 2006 Dec; 26(10):1217-24. PubMed ID: 17105587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum tissue polypeptide antigen (S-TPA) in bladder cancer as a tumor marker. A prospective study.
    Maulard C; Toubert ME; Chretien Y; Delanian S; Dufour B; Housset M
    Cancer; 1994 Jan; 73(2):394-8. PubMed ID: 8293406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical significance of serum tissue polypeptide antigen as a tumor marker for urogenital carcinomas--a comparison with other tumor markers in patients with renal cell carcinoma and prostatic carcinoma].
    Yamazaki K; Kumamoto Y; Tsukamoto T; Umehara T; Ohmura K
    Hinyokika Kiyo; 1987 Oct; 33(10):1581-9. PubMed ID: 2451408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to liver membrane antigens in chronic active hepatitis (CAH). II. Specificity for autoimmune CAH.
    Frazer IH; Kronborg IJ; Mackay IR
    Clin Exp Immunol; 1983 Oct; 54(1):213-8. PubMed ID: 6616969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.